Recent Advances in Mercury Research

Abstract

Mercury (Hg) is a highly toxic, non-essential, naturally occurring metal with a variety of uses. Mercury is not required for any known biological process and its presence in the human body may be detrimental, especially to the nervous system. Both genetic and behavioral studies suggest that mercury levels, age (both of exposure and at testing), and genetic background determine disease processes and outcome. The metal receptors and genes responsible for mercury metabolism also appear to play a pivotal role in the etiology of mercury-induced pathology. This review presents information about the latest advances in mercury research, with particular focus on low-level exposures and the contribution of genetics to toxic outcome. Future studies should address the contribution of genetics and low-level mercury exposure to disease, namely gene x environment interactions, taking into consideration age of exposure as developing animals are exquisitely more sensitive to this metal. In addition to recent advances in understanding the pathology associated with mercury exposure, the review highlights transport mechanisms, cellular distribution and detoxification of mercury species in the body.

Introduction

Mercury (Hg) is a naturally occurring element present in the Earth’s crust. Although present in the environment and atmosphere in small quantities, it is a source of concern due to its considerable release through anthropogenic emissions. Mercury toxicity is not limited to humans; it is also detrimental to animals and plants [1]. The mechanisms through which it causes cell death are of particular interest and this has received considerable attention [2•]. Mercury has a rich history; its applications have varied from extracting gold (which remains a common practice in developing countries) to treating everything from constipation to syphilis. Many believe that the character of the ‘Mad Hatter’ in Alice in Wonderland was based on English hatters who were poisoned by mercuric nitrate used in the felting process [3].

Natural sources of mercury in the environment include elemental mercury vapor from volcanoes and forest fires and the release of inorganic mercury by weathering and movement of water [4]. More recent anthropogenic sources include burning of coal and fossil fuels, mining of mercury, precious metal refinement, electrical and automotive part manufacture, and chemical processing, and release through waste incineration, landfills, and industrial contamination of water systems.

Some of the best-known environmental effects of mercury on human health come from Minamata, Japan, and Iraq secondary to consumption of tainted fish and wheat, respectively. In Minamata, over the course of several years industrial waste-water containing mercury was released into the environment and bioaccumulated in fish. In the 1950s, adults who consumed the mercury-laced fish developed Minamata disease, which was eventually characterized by paresthesia, sensory deficits, slurred speech, unsteady gait, muscle weakness, irritability, memory loss, and depression [2•]. Similar symptoms were observed in Iraq after consumption of bread made from grain treated with ethylmercury [2•]. Methylmercury (MeHg) contamination of fish is still a significant source of human exposure to mercury compounds in fish-eating populations.

Because mercury in the environment poses a significant risk to human health it, is regulated by the United States Environmental Protection Agency (US EPA) and the Occupation Health and Safety Agency (OSHA). These agencies take recommendations from the National Academy of Sciences expert panels that review available scientific studies and make safe level recommendations. It is recommended that levels of mercury not exceed 5.0 μg/L in whole blood or 1.0 μg/g hair, which corresponds to a reference dose of 0.1 μg/kg body weight/day [5].

The FDA also limits the amount of mercury in cosmetic products to 1 ppm. In a study conducted in 2013, 549 skin-lightening products, manufactured in 32 countries, purchased both online and in stores in the USA, Taiwan, Japan, China, Thailand, and Sri Lanka were tested for mercury levels. Cosmetics were screened for mercury content above 200 ppm using a low-cost portable x-ray fluorescence spectrometer. Of the 549 tested products, 33, representing ~6.0 %, contained mercury above 1,000 ppm. Forty-five percent contained mercury in excess of 10,000 ppm and 3.3 % of skin-lightening products purchased in the USA were found to contain mercury in excess of 1,000 ppm [6].

Mercury is a very potent toxicant, with the nervous system, particularly the developing nervous system, being the most affected. Various mercury research studies have emerged in the last few years and the number is too vast to review all of them here, but common ‘themes’ have appeared, such as studies of low-level mercury exposure, and the contribution of genetics to mercury toxicity. The most recent of these studies are reviewed herein. A background of mercury administration, distribution, metabolism, and excretion is provided for context.

Mercury Species

Mercury, also known as quicksilver, is the only metal that is liquid at room temperature. There are three primary forms of mercury: elemental or metallic mercury (Hg⁰), inorganic mercury, and organic mercury. Hg⁰ is a silver-colored liquid at room temperature but forms mercury vapors at ambient temperatures due to its very high vapor pressure. These characteristics have made mercury particularly valuable for use in production of chlorine gas and caustic soda, extraction of gold and silver from ore, and as a component of batteries, dental amalgam, thermometers, barometers, and electrical switches (Table 1). Elemental mercury is rarely found in nature but can be heat-extracted from inorganic cinnabar ores. Mercuric mercury (Hg²⁺) is the oxidation state that is most commonly found.

Table 1.

Sources, uses, half-life, and notes on absorption, distribution, and metabolism of mercury

Classification	Common nomenclature	Uses	Sources	Half-life	Notes on absorption, distribution, and metabolism
Elemental or metallic mercury	Hg	Metal refinement; electrical components; production of chlorine gas and caustic soda; batteries; dental amalgam; thermometers; barometers	Cinnabar ore; occupational exposure (i.e., waste disposal, electrical and auto parts manufacturing, chemical processing, metal processing, dental occupation, construction, painters); dental fillings; broken light bulbs	1–3 days in blood, followed by a slower half-life of 1–3 weeks; 1–3 months for urinary levels	Absorption can occur through dermal contact, ingestion, and/or inhalation of vapors (inhalation is the most significant source); enters all tissues and accumulates in the central nervous system and kidneys
Inorganic: mercuric mercury; mercury chloride; mercurous mercury	Hg2+ (mercuric)	Cosmetics; disinfectant; laxative	Mineral deposits; industrial waste	Similar to slow-phase half-life of elemental mercury	Small portion absorbed from the GI tract (<15 %); accumulates mostly in kidneys and liver; excreted in urine and feces; can be transformed by methanogens and sulfate-reducing bacteria to methylmercury
Organic: methylmercury; ethylmercury	CH3Hg (MeHg)	Fungicide	Fish and other seafood	~50 days in blood	High (~95 %) absorption from GI tract; absorbed in intestine then incorporated into bile; enters enterohepatic circulation; distributed to all tissues, especially brain; excreted in feces; incorporated into growing hair
	Ethylmercury	Vaccine preservative	Vaccines		Metabolized to Hg2+; highest levels found in kidney (very little accumulating in neural tissues)

GI gastrointestinal

MeHg is the form of mercury that is highly neurotoxic and exerts most of the toxicity commonly associated with mercurials. Depending on the depth and oxygen content of waters, Hg²⁺ and mercury sulfide (HgS) can be transformed by methanogens and sulfate-reducing bacteria to MeHg. Because MeHg has a higher bioavailability than elemental and inorganic compounds, and because it is highly lipid soluble, it can diffuse out of the cell and can accumulate in waters where it can be absorbed by bottom feeders such as zooplankton and other small organisms. These organisms are consumed by small fish, which are then eaten by larger fish, resulting in mercury bioaccumulation the higher you go up the food chain. Due to bioaccumulation and slow excretion rates, MeHg is concentrated by as much as a million fold in larger predatory fish relative to the surrounding water [7]; this is particularly problematic for fish that have more fat due to mercury’s high lipid solubility [8].

Sources

Humans absorb MeHg and Hg²⁺ naturally through ingestion of contaminated fish and plants. Cellular fractions of muscle tissue from several species of commercially farmed fish were analyzed for mercury species/content. The highest levels of total mercury were found bound to cellular debris and the metallothionein-like pool [9]. This sequestration of mercury at the tissue and cellular level may reduce the toxicity of mercury to the fish, but unfortunately contributes to the high concentrations of mercury present in fish.

Occupational exposure and anthropogenic mercury emissions can also present significant sources of mercury exposure to humans. Human exposure to Hg⁰can occur through dermal contact, ingestion, and/or through inhalation of vapors. Occupations with reported mercury exposures are waste disposal, electrical and auto parts manufacturing, chemical processing, metal processing, dental occupations, construction, and house painting. Non-dietary, non-occupational sources of exposure are mercury spills from broken light bulbs or thermometers and from dental fillings.

Absorption, Transport, and Detoxification

The absorption, transport, and detoxification of mercury is dependent on the mercury species. For elemental and inorganic mercury, inhalation of mercury vapors is the most significant source of absorption, with as much as 80 % of the inhaled vapors directly entering the bloodstream. Upon absorption, elemental mercury enters all tissues and accumulates in the central nervous system and kidneys. Inorganic mercury has low lipid solubility and does not readily cross cell membranes. Once absorbed, the majority of Hg²⁺ accumulates in the kidney and liver (Table 1).

As much as 90 % of ingested MeHg is absorbed through the intestine and forms thiol (-SH) complexes with proteins and amino acids [such as glutathione (GSH) and cysteine] in the liver. Some MeHg enters the general circulation, where it is distributed throughout all tissues including the brain (Table 1). However, most of the absorbed MeHg is incorporated into bile, secreted into the intestine, and reabsorbed through the enterohepatic circulation. Other organomercurials, such as ethylmercury, are metabolized to Hg²⁺ more rapidly (the longer the alkyl chain of the organic mercury compound, the more it behaves as inorganic Hg²⁺), and therefore have different tissue accumulation. Similar to Hg²⁺, the highest levels of ethylmercury are found in the kidney, with very little accumulating in neural tissues [10•, 11].

Mercury has high affinity for thiol (-SH) and selenol (-SeH) groups; these groups are used primarily for mercury transport both through cells and through the body. Metallothionein and GSH are examples of thiol-rich intracellular proteins. Selenoproteins include GSH peroxidase, iodothyronine deiodinase, thioredoxin reductase, and selenoprotein P. Cysteine residues on serum albumin and hemoglobin are used to transport ~90 % of Hg²⁺ and MeHg in plasma. Globins and other plasma proteins including selenoprotein P are responsible for the remaining percentage. MeHg in blood is found conjugated with GSH in erythrocytes [12, 13].

In addition to transport, detoxification of Hg²⁺ and MeHg species can also occur through complexation with GSH. GSH–mercury complexes facilitate systemic excretion through the liver (bile) and kidneys as well as cellular efflux of MeHg from astrocytes [14]. The affinity of inorganic and organic mercury compounds is higher for selenol groups than for thiol groups [15–17].

Neurotoxicity

It is readily established that MeHg disrupts the nervous system, yet the mechanism of damage remains poorly understood. Before mercury can have an effect, it must first cross several barriers. Several studies support that MeHg-L-cysteine is transported across the blood–brain barrier by the L-type amino acid transporters used to transport neutral amino acids [18], as was first observed by Aschner et al., who observed competitive inhibition of MeHg uptake in astrocytes by large, neutral amino acids [19, 20].

Low-level Mercury Exposure Studies (Humans)

Few studies have evaluated the neurobehavioral effects of mercury exposure in adult populations. A Korean group of researchers [21] studied the association between low-level mercury exposure and neurobehavioral functions in adults aged 20–65 years living in coastal regions of the country. The mean mercury level in the blood was 5.41 μg/L, in urine was 1.17 μg/g-creatinine, and in hair was 1.37 mg/kg. The only significant result was an association between right-hand finger taps and urine mercury levels, which suggests that low-level mercury exposure in adults is not associated with deficits in neurobehavioral functions [21].

The objective of the Flemish biomonitoring program FLEHS I, conducted from 2002 to 2006, was to study regional exposure levels in an attempt to link possible differences in internal exposure levels to local environmental pressure. In the second installment of the program, FLEHS II, conducted from 2007 to 2011, the main objectives were to determine reference levels of mercury in hair for the population of Flanders, Belgium, to assess relationships between mercury exposure and possible sources such as fish consumption, and to assess dose–effect relationships between mercury exposure and health effect markers. The study consisted of approximately 200 adolescents and 250 mothers as a reference. The results revealed that mercury concentrations in the Flemish population were rather low compared with other studies. Mercury levels in the Flemish populations were strongly related to the age of the participants and seafood intake. Asthma, having been breastfed as a newborn, age of menarche, allergy for animals, and free testosterone levels were negatively associated with mercury in hair. Janus kinase 2 (JAK2), ARID4A, Hist1HA4L (boys) and HLAdrb5, PIAS2, MANN1B1, GIT and ABCA1 (girls) were also significantly correlated with mercury levels in hair [22].

In addition to Minamata and Iraq, there was another mercury epidemic in Niigata, Japan, in the 1960s. During this epidemic two extensive surveys were collected, but cases diagnosed after the epidemic or those exposed to low levels of MeHg (hair mercury level <50 μg/g) were not well-documented. From these two surveys, Maruyama and colleagues examined 103 adults with hair mercury measurements and compared the prevalence and distribution of neurological signs related to MeHg poisoning between exposure categories. They found 48 subjects with neurological signs, such as sensory disturbance of bilateral distal extremities, disequilibrium, hearing impairment and ataxia, in the MeHg group with a hair mercury concentration <50 μg/g [23].

A study conducted in Hong Kong children examined the association between low-dose prenatal MeHg exposure and neurocognitive outcomes. 608 subjects were assessed using the Hong Kong Wechsler Intelligence Scale for Children (HK-WISC), Hong Kong List Learning Test (HKLLT), Tests of Everyday Attention for Children (TEACH), Boston Naming Test, and Grooved Pegboard Test. After correcting for child age and sex, multivariate analysis showed a negative correlation between the cord blood mercury concentration and the Picture Arrangement of HK-WISC, and Short and Long Delay Recall Difference of the HKLLT subtests. Small adverse associations were also found between prenatal MeHg exposure and long-term neurocognitive effects as measured via the visual sequencing task and retention ability of verbal memory [24].

Low-level Mercury Exposure Studies (Animals and Cell Models)

A number of studies have evaluated the role of low-dose mercury in neurodevelopmental toxicity in animal models. The effects of low-dose prenatal MeHg on neuronal migration in the developing rat cerebral cortex were assessed using in utero electroporation. Offspring of rats exposed prenatally during the critical stage in neuronal migration exhibited migration defects of the cerebrocortical neurons. Altered proliferation of neural progenitor cells (NPCs), induction of apoptosis of NPCs or newborn neurons, abnormal differentiation of NPCs, and the morphological changes of radial glial scaffold were ruled out as the sources of the abnormal neuronal distribution, suggesting that the defective neuronal positioning triggered by exposure to a low-dose of MeHg was due to the impacts of MeHg on the process of neuronal migration itself. In utero exposure to low-level MeHg also suppressed the expression of Rac1, Cdc42, and RhoA, key players in migration of cerebrocortical neurons during the early stage of brain development [25].

To examine whether low doses of MeHg (30–300 nM) and mercury chloride (HgCl₂) could modulate the activity of the JAK/signal transducer and activator of transcription (STAT) signaling pathway, Jebbett and colleagues [26] used human SH-SY5Y neuroblastoma and mouse cortical NPCs. They showed enhanced ciliary neurotrophic factor (CNTF)-evoked STAT3 phosphorylation in both cell lines following sub-cytotoxic doses of MeHg. This effect was specific for MeHg, as HgCl₂ did not enhance signaling. The NPCs further showed enhanced CNTF-induced expression of STAT3 target genes such as glial fibrillary acidic protein (GFAP) and suppressed cytokine signaling 3 (SOCS3), and increased the proportion of cells expressing GFAP following 2 days of differentiation following MeHg exposure. Higher, near-cytotoxic concentrations of MeHg and HgCl₂ inhibited STAT3 phosphorylation and led to increased production of superoxide. Lower concentrations of MeHg activated JAK/STAT signaling but did not result in a detectable increase in superoxide or increased expression of heme oxygenase 1, heat shock protein A5, and sirtuin 1. These findings suggest that low concentrations of MeHg can enhance STAT3 phosphorylation and glial differentiation through an alternative mechanism than that of reactive oxygen species (ROS) and cell death [26].

Contribution of Genetics to Methylmercury Toxicity

Recent studies suggest that several genes mediating the toxicokinetics of mercury are polymorphic in humans and may be responsible for inter-individual variability.

Using a subsample (n=1,311) of the Avon Longitudinal Study of Parents and Children (Bristol, UK), Grandjean and colleagues [27] measured mercury content from freeze-dried umbilical cord tissue as well as sociodemographic cofactors, nutrition, genetic polymorphisms, and the Wechsler Intelligence Scale for Children Intelligence Quotient (IQ) scores at age 8 years to account for cognitive ability [28]. Children in this study had low background mercury exposures. They showed a positive association between Log10-transformed mercury and IQ scores, but this association did not withstand adjustment for nutritional and sociodemographic co-factors. The authors used the Illumina^® HumanHap550 quad chip genotyping platform by 23andMe to look for single nucleotide polymorphisms (SNPs) on candidate genes belonging to brain development and neurotransmitter metabolism, cholesterol metabolism, iron regulation, and peroxidative defense. MeHg interactions (MeHg× total IQ) were detected for three SNPs including paraoxonase 1 (rs662), progesterone receptor (rs1042838), and brain-derived neurotrophic factor (rs2049046), and transferrin (rs3811647) was associated with mercury concentrations. There were only equivocal associations between MeHg exposure and adverse neuropsychological outcomes. Interestingly, they did find heterogeneities in several relevant genes, which the authors suggest could mean an increased predisposition to MeHg neurotoxicity [27].

In a study in dental professionals, Goodrich and colleagues studied polymorphisms in key GSH-synthesizing enzyme, GSH s-transferase, and selenoprotein genes underlying inter-individual differences in mercury body burden. They used urine as a biomarker for elemental mercury and hair as a biomarker for MeHg and concluded that the average urine (1.06±1.24 μg/L) and hair mercury levels (0.49±0.63 μg/g) were similar to national US population averages. TaqMan assays were used to genotype DNA from buccal swab samples at 15 polymorphic sites in genes implicated in mercury metabolism. Linear regression modeling assessed the ability of polymorphisms to modify the relationship between mercury biomarker levels and exposure sources (e.g., amalgams, fish consumption). Five polymorphisms were significantly associated with urine mercury levels (GSTT1 deletion), hair mercury levels (GSTP1-105, GSTP1-114, GSS 5′), or both (SEPP1 3′UTR). This study suggests that polymorphisms in selenoproteins and GSH-related genes may influence elimination of elemental mercury and MeHg [28].

Autism is a common neurodevelopmental disorder with suspected genetic and environmental components. Genetic susceptibility to high mercury has been suggested as an autism risk factor for some children. Owens and colleagues [29] hypothesized that mercury could be implicated in the etiology of autism if genetic susceptibility altered its metabolism or intracellular compartmentalization. Genetic sequences of four genes, L-type amino acid transporter 1 (LAT1), divalent metal transporter 1 (DMT1), metal-regulatory transcription factor 1 (MTF1), and metallothionein 1a (MT1a), implicated in the transport of and response to mercury were screened for variation and association with autism. They identified and characterized 74 variants in these four genes and polymorphisms through screening 48 unrelated individuals from the general and autistic populations who were evaluated for differences in allele frequencies. Analysis failed to show an association with autism for any variant evaluated, suggesting that variations in the ability of these genes to process and transport mercury may not play a significant role in the etiology of autism [29].

Another study examined the role of the endothelial nitric oxide (eNOS) gene polymorphisms, T-786C and Glu298Asp, on nitrite concentrations following mercury exposure in humans under the premise that mercury exposure might decrease circulating nitrite concentrations and that variants in the eNOS gene might enhance the adverse effects of mercury, resulting in increased risk of cardiovascular disease. Blood samples were collected from volunteers exposed to MeHg following fish consumption. There were no significant differences in age, arterial blood pressure, body mass index, heart rate, and concentrations of mercury and nitrite concentrations between the genotype groups. Decreased nitric oxide (NO) production was attributed to mercury, age, and gender and was not influenced by gene polymorphisms. Their findings suggest that T-786C and Glu298Asp were not associated with an increased risk for cardiovascular diseases in MeHg-exposed subjects [30]. The same group investigated the contribution of the 27-nt tandem repeat of intron 4 of the eNOS gene on NO production, which could enhance susceptibility to cardiovascular disease in the MeHg-exposed study population. They found no significant differences in age, arterial blood pressure, body mass index, or cardiac frequency between genotype groups but observed lower nitrite levels for the 4a4a genotype carriers. Age, gender, and the presence of the intron 4 polymorphism contributed to nitrite reduction as a result of the blood mercury concentration. Their results suggested that the 27 nt repeat polymorphism of intron 4 in the eNOS gene increases susceptibility to cardiovascular diseases after MeHg exposure by modulating NO levels [31].

The n-3 polyunsaturated fatty acids eicosapentaenoic acid and docosahexaenoic acid, which are present in fish, are protective against myocardial infarction (MI). However, the risk of MI can also be influenced by MeHg contamination of fish. Engström and colleagues elucidated whether genetic polymorphisms in GSH-related genes modify the association between eicosapentaenoic+docosahexaenoic acid or MeHg and the risk of first-ever MI. Individuals from northern Sweden were genotyped to examine polymorphisms in GSH-synthesizing or GSH-conjugating genes. The impact of these polymorphisms on the association between erythrocyte-mercury (proxy for MeHg) and the risk of MI, as well as between plasma eicosapentaenoic+docosahexaenoic acid and the risk of MI, was evaluated, while also considering the effect of erythrocyte-selenium on the risk of MI. There were no strong genetic modifying effects between plasma eicosapentaenoic+docosahexaenoic acid or erythrocyte-Hg and risk of MI. No statistically significant genetic modifying effects were seen for the association between plasma eicosapentaenoic+docosahexaenoic acid or erythrocyte-mercury and the risk of MI (summarized in Table 2) [32].

Table 2.

Summary of genetic studies in humans

Population	Measured	Significant findings	Reference
Subset of the Avon Longitudinal Study of Parents and Children (Bristol, UK)	Hg content from freeze-dried umbilical cord tissue; sociodemographic cofactors, nutrition, genetic polymorphisms; Wechsler Intelligence Scale for children IQ at age 8 years	MeHg×total IQ interactions detected for paraoxonase 1 (rs662), progesterone receptor (rs1042838), and brain-derived neurotrophic factor (rs2049046); transferrin (rs3811647) were associated with Hg concentrations	Julvez et al., 2013 [27]
Dental professionals	Polymorphisms in key GSH-synthesizing enzymes	Five polymorphisms were significantly associated with urine Hg levels (GSTT1 deletion), hair Hg levels (GSTP1-105, GSTP1-114, GSS 5′), or both (SEPP1 3′UTR)	Goodrich et al., 2011 [28]
General and autistic populations	Genetic sequences of four genes, L-type amino acid transporter 1 (LAT1), divalent metal transporter 1 (DMT1), metal-regulatory transcription factor 1 (MTF1), and metallothionein 1a (MT1a)	Analysis failed to show association with autism for any variant evaluated, suggesting that variations in the ability of these genes to process and transport Hg may not play a significant role in the etiology of autism	Owens et al., 2011 [29]
Volunteers exposed to MeHg following fish consumption	Role of eNOS gene polymorphisms (T-786C and Glu298Asp) on nitrite concentrations following Hg exposure	• T-786C and Glu298Asp were not associated with an increased risk for cardiovascular diseases in MeHg-exposed subjects • Age, gender, and the presence of intron 4 polymorphism contributed to nitrite reduction as a result of blood Hg concentration • The 27 nt repeat polymorphism of intron 4 in the eNOS gene increases susceptibility to cardiovascular diseases after MeHg exposure by modulating NO levels	de Marco et al., 2012 [31]
Individuals from Northern Sweden	Polymorphisms in GSH-synthesizing or GSH-conjugating genes and MeHg and risk of MI	No statistically significant genetic modifying effects were seen for the association between plasma eicosapentaenoic+docosahexaenoic acid or erythrocyte-Hg and risk of MI	Engström et al., 2011 [32]

eNOS endothelial nitric oxide, GSH glutathione, Hg mercury, IQ intelligence quotient, MeHg methylmercury, MI myocardial infarction, NO nitric oxide

Resistance to mercury is widely distributed among bacteria isolated from healthy adults and children, with the presence of mercury resistance genes almost always associated with the concomitant presence of antibiotic resistance genes [33–40]. This association between antibiotic resistance and heavy metal resistance has also been described in Staphylococcus aureus.

Studies in Caenorhabditis elegans conducted by Martinez-Finley and colleagues have shown a latency period for neurodegeneration in combination with susceptibility of genetic background [41, 42]. The first study described the impact of early-life exposure to MeHg and knockdown of skn-1, the major stress-activated cytoprotective transcription factor, on dopaminergic (DAergic) neurodegeneration, mercury content, and stress reactivity in the nematode C. elegans. Mercury content was not strain dependent; however, the generation of ROS was dramatically increased in skn-1 knockout (KO) compared with wild-type worms. Structural integrity of DAergic neurons was microscopically assessed by visualization of fluorescently-labeled neurons, and revealed loss of neurons in skn-1KO- and MeHg-exposed worms compared with wild-type controls. Dopamine-related behavior in the worms was decreased in response to MeHg exposure and was decreased in skn-1KO worms; both were apparent only after a period of latency. Combined, these studies suggest that knockdown of skn-1 in the nematode increases DAergic sensitivity to MeHg exposure following a period of latency [41].

The second study examined the impact of early-life exposure to MeHg and KO of pdr-1 (mammalian: parkin/PARK2) on measures of stress reactivity, mercury content, and DAergic degeneration under the premise that KO of pdr-1 would exacerbate MeHg toxicity and damage to the DAergic system. pdr-1KO worms showed increased lethality and decreased lifespan following MeHg exposure and also had increased mercury content relative to wild-type worms. ROS were significantly increased in both strains following MeHg exposure; however, while N2 worms showed an increase in skn-1 transcript levels following MeHg, there was no difference in skn-1 induction in pdr-1KO worms, suggesting that they were unable to mount a proper stress response. Dopamine-dependent behavioral analysis revealed an effect of MeHg on N2 wild-type worms, but no effect on pdr-1KO worms. These results suggested that pdr-1KO worms were more sensitive to MeHg than wild-type worms, but MeHg did not exacerbate behavioral changes already present in pdr-1KOs, even after a period of latency [42].

Conclusion

Mercury is a highly toxic, non-essential, naturally occurring metal whose mechanism of toxicity has continued to evade researchers. The current literature provides evidence that mercury toxicity is complex; hence, genetic analyses and testing with low-levelmercury species is likely to provide novel insight into the mechanism of toxicity. Studies (both genetic and behavioral) suggest that the extent of disease may be modulated not only by mercury levels but also by age (both of exposure and at testing) and genetic background. Several studies have pointed to associations between mercury levels and metal receptors (i.e., transferrin) and proteins important for metabolism of mercury (i.e., GSH-synthesizing enzymes) [27, 28]. However, an analysis in autistic individuals did not reveal an association between autism and mercury transport genes [29].

Low-dose mercury exposure was reported to produce neurological signs, such as sensory disturbance of bilateral distal extremities, disequilibrium, hearing impairment, and ataxia [23]. Low-dose mercury was not, however, associated with deficits in neurobehavioral functions in a study in adults [21], yet a genetic study indicated nominal associations between MeHg and paraoxonase 1, progesterone receptor, and brain-derived neurotrophic factor and total IQ (at age 8 years) [27].

Two studies examined the contribution of MeHg to cardiovascular disease and found that polymorphisms in eNOS were not associated with increased risk of cardiovascular disease; however, a polymorphism in intron 4 increased susceptibility to cardiovascular disease after MeHg exposure by modulating NO levels [30, 32]. In addition, plasma eicosapentaenioic+docosahexaenoic acid or erythrocyte-mercury were not found to be associated with the risk of MI [30, 32]. Future studies should aim to address the contribution of genetics and low-level mercury exposure to disease, taking into consideration the age of exposure and the age of testing.